NASDAQ:CNXC

Concentrix Corporation (NASDAQ: CNXC) Reports Mixed Q3 Financial Results

Font: Financial Modeling Prep  • Sep 29, 2026

Market Chart
  • Concentrix Corporation (NASDAQ: CNXC) surpassed analyst expectations with an earnings per share (EPS) of $2.92.
  • Despite strong earnings, revenue for the quarter at $2.45 billion fell slightly short of market forecasts.
  • The company generated a record-high third-quarter free cash flow of $268 million and increased its quarterly dividend.

Concentrix Corporation is a global provider of customer experience (CX) services and technologies. The company helps businesses manage their customer interactions and business processes. On September 29, 2026, Concentrix Corporation reported its financial results for the third quarter, which ended on August 31, 2026, providing a mixed picture of its performance.

The company announced an earnings per share (EPS) of $2.92. This figure surpassed the Zacks Consensus Estimate of $2.71 per share. An EPS represents the portion of a company's profit allocated to each share of stock, so a higher number indicates better profitability than analysts had predicted for the period.

Despite the strong earnings, Concentrix Corporation's revenue for the quarter was $2.45 billion. This amount fell slightly short of the consensus revenue estimate of $2.48 billion, as highlighted by Benzinga Pro. This suggests that while the company was more profitable than expected, its total sales did not meet market forecasts.

On a positive note, the company generated a record-high third-quarter free cash flow from operations of $268 million. Free cash flow is the cash a company produces after accounting for cash outflows to support operations and maintain its capital assets. Concentrix Corporation also increased its quarterly dividend, rewarding its shareholders directly. The current ratio is 1.23 which shows that the company holds more short-term assets than short-term liabilities, suggesting it can cover its immediate financial obligations.

Market Overview
NIVF
NewGenIvf Group Limited
$0.17
133.33%
RETO
ReTo Eco-Solutions, Inc.
$0.11
26.15%
FNGR
FingerMotion, Inc.
$0.18
28.25%
TGE
Generation Essentials Group
$1.55
86.75%
CNTB
Connect Biopharma Holdings Limited
$1.10
10.89%
NVDA
NVIDIA Corporation
$228.38
0.51%
AEON
AEON Biopharma, Inc.
$0.30
15.83%
NU
Nu Holdings Ltd.
$12.66
2.51%
INTC
Intel Corp.
$120.23
3.71%
NVD
GraniteShares 2x Short NVDA Daily ETF
$3.64
-0.55%